Sangamo Therapeutics (SGMO)

• Market cap: $128M
• 1 day: -12.85%
• 5 days: -31.14%
• 1 month: -37.91%
• 3 months: -49.42%
• 6 months: -30.63%
• Year to date: -49.42%
• 1 year: -5.94%
• 5 years: -90.80%
• 10 years: -96.26%
• Sector: Healthcare
• Industry: Biological Products, Except Diagnostic Substances

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

156% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 16

29% more capital invested

Capital invested by funds: $48.7M [Q3] → $62.8M (+$14.2M) [Q4]

23% more funds holding

Funds holding: 103 [Q3] → 127 (+24) [Q4]

2.49% more ownership

Funds ownership: 26.99% [Q3] → 29.48% (+2.49%) [Q4]

7% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 30

44% less call options, than puts

Call options by funds: $1.87M | Put options by funds: $3.36M

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $2 250% upside
• Avg. target: $5.67 892% upside
• High target: $10 1,650% upside

3 analyst ratings

• positive: 2 67%
• neutral: 1 33%
• negative: 0 0%

RBC Capital Luca Issi 22% 1-year accuracy 12 / 55 met price target	250% upside $2	Sector Perform Reiterated	18 Mar 2025
HC Wainwright & Co. Patrick Trucchio 21% 1-year accuracy 38 / 181 met price target	1,650% upside $10	Buy Reiterated	27 Jan 2025
Truist Securities Nicole Germino 67% 1-year accuracy 8 / 12 met price target	775% upside $5	Buy Maintained	23 Jan 2025